Business Analytics & Insights Senior Manager
Amgen
Business Analytics & Insights Senior Manager
Amgen
Makes biotech medicines for serious illnesses
BA&I aims to become a strategic engine of change for the commercial organization by enabling data-driven decision making and delivering the highest level of customer excellence in support of Amgen’s mission to serve patients.
As a key partner to assigned Business Units and cross-functional stakeholders, the BAI Senior Manager leads the generation of actionable business insights, forecasting, and analytics to support business strategy and maximize performance across inline and pipeline products.
This role is expected to operate beyond analytical execution by applying strong business judgment, critical thinking, and analytical rigor to ensure high-quality, insight-driven outputs that support business decision-making. The BAI Senior Manager serves as a trusted partner to Business Unit stakeholders by challenging assumptions, identifying risks and opportunities, and providing an objective and independent perspective grounded in data and market understanding.
The BAI Senior Manager is also responsible for strengthening BAI organizational capabilities by elevating quality standards, improving ways of working, ensuring strong cross-functional collaboration, and creating a high-performing and accountable team environment.
The successful candidate will combine strategic thinking with hands-on leadership, balancing business partnership, people leadership, operational execution, and quality oversight to ensure the delivery of robust, executive-ready, and business-relevant insights across the organization.
The responsibilities of the BAI senior manager are the following:
Strategic Business Partnership
Forecasting Leadership
Insights & Analytics Excellence
Portfolio prioritization and cross-functional alignment
Team leadership and capability building
Qualifications
Experience
Knowledge, and skills
Academic background
Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen